TeleClinical Care - STROKE: A randomised controlled trial of the effect of a comprehensive smartphone application-centric model of care on rates of re-hospitalisation in stroke patients.

The University of New South Wales0 个研究点目标入组 700 人开始时间: 2021年5月18日最近更新: 2024年9月2日

适应症

试验速览

暂无简介。

•Male or female patients >18 years of age.
•Ischaemic stroke/Transient Ischaemic Attack or Primary Intracerebral Haemorrhage (Anticoagulant-Associated Haemorrhage patients are eligible) diagnosed clinically by stroke specialist, with consistent neuro-imaging results and admitted to hospital for diagnosis/treatment.
•Patient (or carer) owns a compatible smartphone and can use the app, wearables and peripherals.
•Enrolment can be performed at the time of discharge from acute care or inpatient rehabilitation
•Informed consent obtained from either the patient or substitute decision maker prior to any study related procedures being performed.

•Patients diagnosed with stroke mimics – such as seizures, migraine, etc.
•Patients with Intracerebral Hemorrhage (ICH) secondary to arteriovenous malformations, intracranial aneurysms, tumours or abscesses. Note: Individuals with small incidental lesions, i.e. a benign lesion such as a small meningioma, are eligible.
•Patients who will not be able to use StandingTall program (such as people who are wheelchair bound, having a physical condition that prevents exercise at home, or not feasible of using StandingTall judged by the rehabilitation team)
•Co-morbid illness with expected life expectancy of <6 months.

发起方